Cha Albert 4

4 · KalVista Pharmaceuticals, Inc. · Filed Oct 3, 2019

Insider Transaction Report

Form 4
Period: 2019-10-02
CHA ALBERT
Director
Transactions
  • Award

    Director Stock Option (Right to Buy)

    2019-10-02+7,0007,000 total
    Exercise: $11.21Exp: 2029-10-01Common Stock (7,000 underlying)
Footnotes (1)
  • [F1]The option vests over a 12 month period: 1/12th on November 2, 2019, after which 1/12th of the total shares vest monthly, subject to continued service through each vesting date.

Documents

1 file
  • 4
    doc1.xmlPrimary

    FORM 4